In November this year, the Japanese pharmaceutical firm Takeda inaugurated its first dengue vaccine manufacturing plant in Singen, Germany. The Singen vaccine plant ultimately aims to offer end-to-end production of the vaccine, including formulation, fill, finish and secondary packaging of the current Takeda dengue vaccine candidate. This plant is located on the premises of one out of 34 production sites of Takeda’s extensive network in 20 different countries serving a wide r

Dr. Prudence Hamade, Senior Technical Officer at the Malaria Consortium, speaks about current strategies to tackle dengue fever, focusing on programmes using biocontrol (guppy fish), larvicides and communication for behavioural impact (COMBI) in Cambodia. Recorded at the Dengue Side Event at the 72nd World Health Assembly, hosted by the International Society for Neglected Tropical Diseases on May 24th 2019. Link to the complete playlist of presentations at the WHA72 Dengue Si

Pr. Annelies Wilder-Smith from the World Health Organisation and the London School of Hygiene & Tropical Medicine describes the complexities of developing a dengue vaccine and outlines the lessons learnt and next steps derived from the first dengue vaccine. Recorded at the Dengue Side Event at the 72nd World Health Assembly, hosted by the International Society for Neglected Tropical Diseases on May 24th 2019. Link to the complete playlist of presentations at the WHA72 Dengue

Dr. Derric Nimmo from the IVCC speaks about the current challenges in insecticides to tackle disease-carrying insects and the role of product development partnerships in controlling insect vectors of disease. Recorded at the Dengue Side Event at the 72nd World Health Assembly, hosted by the International Society for Neglected Tropical Diseases on May 24th 2019. Link to the complete playlist of presentations at the WHA72 Dengue Side Event Link to the full programme of the WHA7

Benjamin Willis from the MENTOR Initiative speaks about the threat of dengue and vector-borne diseases in humanitarian crises, and the MENTOR Initiative's strategies to prevent and tackle outbreaks. Recorded at the Dengue Side Event at the 72nd World Health Assembly, hosted by the International Society for Neglected Tropical Diseases on May 24th 2019. Link to the complete playlist of presentations at the WHA72 Dengue Side Event Link to the full programme of the WHA72 Dengue S

Dr. Rachel Lowe from the London School of Hygiene & Tropical Medicine speaks about climate change and its impact on the expansion of Aedes vectors and the spread of dengue, and describes ongoing research on climate-driven early warning systems for dengue. Recorded at the Dengue Side Event at the 72nd World Health Assembly, hosted by the International Society for Neglected Tropical Diseases on May 24th 2019. Link to the complete playlist of presentations at the WHA72 Dengue Si

Dr. Nakorn Premsri, from the National Vaccine Institute & the Ministry Public Health Thailand, outlines the burden of dengue in Thailand as well as some of the strategies deployed to tackle outbreaks, vectors and inform communities. Recorded at the Dengue Side Event at the 72nd World Health Assembly, hosted by the International Society for Neglected Tropical Diseases on May 24th 2019. Link to the complete playlist of presentations at the WHA72 Dengue Side Event Link to the fu

Dr. Raman Velayudhan is Coordinator of the Vector Ecology & Management Unit at the World Health Organisation's Department for the Control of Neglected Tropical Diseases. Speaking at the Dengue Side Event at the 72nd World Health Assembly, Dr. Velayudhan outlines the current challenges associated with the spread of Aedes mosquitoes, the increase in dengue outbreaks and global risk, as well as the response and strategies needed to control this, with a focus on the WHO's Global

Dr. Mwele Malecela, Director of the Department for the Control of Neglected Tropical Diseases at the World Health Organisation, speaks about the current threat of dengue and neglected tropical diseases worldwide as well as the WHO's integrated approach to tackle these challenges, with a focus on the Global Vector Control Response strategy. Recorded at the Dengue Side Event at the 72nd World Health Assembly, hosted by the International Society for Neglected Tropical Diseases o

This month, the US Food and Drug Administration (FDA) announced its approval of the dengue vaccine, Dengvaxia, setting an important milestone in the prevention of dengue fever, the world's most common mosquito-borne viral disease which annually affects over 400 million people worldwide and kills over 20,000. The approval will boost outcomes for a large number of individuals at risk in dengue-endemic regions as there is currently no cure for dengue. For the US, the majority of